236 related articles for article (PubMed ID: 19782074)
41. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects.
Katragadda S; Arora RR
Am J Ther; 2010; 17(1):e11-23. PubMed ID: 20090429
[TBL] [Abstract][Full Text] [Related]
42. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
43. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
Pichler M; Klein W; Huber K; Pachinger O
Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
[TBL] [Abstract][Full Text] [Related]
44. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
Doulton TW; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):185-9. PubMed ID: 19617273
[TBL] [Abstract][Full Text] [Related]
45. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
Ribeiro VT; de Souza LC; Simões E Silva AC
Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
[TBL] [Abstract][Full Text] [Related]
46. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
47. Do angiotensin receptor blockers prevent Alzheimer's disease?
Hajjar I; Rodgers K
Curr Opin Cardiol; 2013 Jul; 28(4):417-25. PubMed ID: 23703253
[TBL] [Abstract][Full Text] [Related]
48. Brain renin-angiotensin--a new look at an old system.
Wright JW; Harding JW
Prog Neurobiol; 2011 Sep; 95(1):49-67. PubMed ID: 21777652
[TBL] [Abstract][Full Text] [Related]
49. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
Royea J; Hamel E
Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Rescue Memory Defects in
Lee SH; Gomes SM; Ghalayini J; Iliadi KG; Boulianne GL
eNeuro; 2020; 7(6):. PubMed ID: 33060184
[TBL] [Abstract][Full Text] [Related]
51. Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease.
Wright JW; Harding JW
J Alzheimers Dis; 2019; 67(2):469-480. PubMed ID: 30664507
[TBL] [Abstract][Full Text] [Related]
52. The depressor axis of the renin-angiotensin system and brain disorders: a translational approach.
Gironacci MM; Vicario A; Cerezo G; Silva MG
Clin Sci (Lond); 2018 May; 132(10):1021-1038. PubMed ID: 29802208
[TBL] [Abstract][Full Text] [Related]
53. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease.
Mateos L; Ismail MA; Gil-Bea FJ; Leoni V; Winblad B; Björkhem I; Cedazo-Mínguez A
J Alzheimers Dis; 2011; 24(4):669-79. PubMed ID: 21297254
[TBL] [Abstract][Full Text] [Related]
54. Renin-angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease.
Furiya Y; Ryo M; Kawahara M; Kiriyama T; Morikawa M; Ueno S
Alzheimers Dement; 2013 Sep; 9(5):512-8. PubMed ID: 23142434
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
[TBL] [Abstract][Full Text] [Related]
56. Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues.
Torsello A; Bresciani E; Ravelli M; Rizzi L; Bulgarelli I; Ricci G; Ghiazza B; Del Puppo M; Mainini V; Omeljaniuk RJ; Tamiazzo L; Mancia G; Magni F; Locatelli V
Pharmacol Res; 2012 Oct; 66(4):317-24. PubMed ID: 22732396
[TBL] [Abstract][Full Text] [Related]
57. [Novel Abeta-converting activity of angiotensin-converting enzyme and its role in Alzheimer's disease].
Zou K; Michikawa M; Komano H
Seikagaku; 2010 Dec; 82(12):1120-4. PubMed ID: 21348266
[No Abstract] [Full Text] [Related]
58. Renin Angiotensin aldosterone system inhibition in controlling dementia-related cognitive decline.
O'Caoimh R; Kehoe PG; Molloy DW
J Alzheimers Dis; 2014; 42 Suppl 4():S575-86. PubMed ID: 25182739
[TBL] [Abstract][Full Text] [Related]
59. Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system.
Quitterer U; AbdAlla S
Pharmacol Res; 2020 Apr; 154():104230. PubMed ID: 30991105
[TBL] [Abstract][Full Text] [Related]
60. Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
Li X; Xuan W; Chen D; Gao H; Wang G; Guo Q; Wang Y; Song H; Cai B
J Alzheimers Dis; 2020; 78(4):1315-1338. PubMed ID: 33164932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
